Cargando…
Biofilms: Novel Strategies Based on Antimicrobial Peptides
The problem of drug resistance is very worrying and ever increasing. Resistance is due not only to the reckless use of antibiotics but also to the fact that pathogens are able to adapt to different conditions and develop self-defense mechanisms such as living in biofilms; altogether these issues mak...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680976/ https://www.ncbi.nlm.nih.gov/pubmed/31295834 http://dx.doi.org/10.3390/pharmaceutics11070322 |
_version_ | 1783441625871024128 |
---|---|
author | Galdiero, Emilia Lombardi, Lucia Falanga, Annarita Libralato, Giovanni Guida, Marco Carotenuto, Rosa |
author_facet | Galdiero, Emilia Lombardi, Lucia Falanga, Annarita Libralato, Giovanni Guida, Marco Carotenuto, Rosa |
author_sort | Galdiero, Emilia |
collection | PubMed |
description | The problem of drug resistance is very worrying and ever increasing. Resistance is due not only to the reckless use of antibiotics but also to the fact that pathogens are able to adapt to different conditions and develop self-defense mechanisms such as living in biofilms; altogether these issues make the search for alternative drugs a real challenge. Antimicrobial peptides appear as promising alternatives but they have disadvantages that do not make them easily applicable in the medical field; thus many researches look for solutions to overcome the disadvantages and ensure that the advantages can be exploited. This review describes the biofilm characteristics and identifies the key features that antimicrobial peptides should have. Recalcitrant bacterial infections caused by the most obstinate bacterial species should be treated with a strategy to combine conventional peptides functionalized with nano-tools. This approach could effectively disrupt high density infections caused by biofilms. Moreover, the importance of using in vivo non mammalian models for biofilm studies is described. In particular, here we analyze the use of amphibians as a model to substitute the rodent model. |
format | Online Article Text |
id | pubmed-6680976 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66809762019-08-09 Biofilms: Novel Strategies Based on Antimicrobial Peptides Galdiero, Emilia Lombardi, Lucia Falanga, Annarita Libralato, Giovanni Guida, Marco Carotenuto, Rosa Pharmaceutics Review The problem of drug resistance is very worrying and ever increasing. Resistance is due not only to the reckless use of antibiotics but also to the fact that pathogens are able to adapt to different conditions and develop self-defense mechanisms such as living in biofilms; altogether these issues make the search for alternative drugs a real challenge. Antimicrobial peptides appear as promising alternatives but they have disadvantages that do not make them easily applicable in the medical field; thus many researches look for solutions to overcome the disadvantages and ensure that the advantages can be exploited. This review describes the biofilm characteristics and identifies the key features that antimicrobial peptides should have. Recalcitrant bacterial infections caused by the most obstinate bacterial species should be treated with a strategy to combine conventional peptides functionalized with nano-tools. This approach could effectively disrupt high density infections caused by biofilms. Moreover, the importance of using in vivo non mammalian models for biofilm studies is described. In particular, here we analyze the use of amphibians as a model to substitute the rodent model. MDPI 2019-07-10 /pmc/articles/PMC6680976/ /pubmed/31295834 http://dx.doi.org/10.3390/pharmaceutics11070322 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Galdiero, Emilia Lombardi, Lucia Falanga, Annarita Libralato, Giovanni Guida, Marco Carotenuto, Rosa Biofilms: Novel Strategies Based on Antimicrobial Peptides |
title | Biofilms: Novel Strategies Based on Antimicrobial Peptides |
title_full | Biofilms: Novel Strategies Based on Antimicrobial Peptides |
title_fullStr | Biofilms: Novel Strategies Based on Antimicrobial Peptides |
title_full_unstemmed | Biofilms: Novel Strategies Based on Antimicrobial Peptides |
title_short | Biofilms: Novel Strategies Based on Antimicrobial Peptides |
title_sort | biofilms: novel strategies based on antimicrobial peptides |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680976/ https://www.ncbi.nlm.nih.gov/pubmed/31295834 http://dx.doi.org/10.3390/pharmaceutics11070322 |
work_keys_str_mv | AT galdieroemilia biofilmsnovelstrategiesbasedonantimicrobialpeptides AT lombardilucia biofilmsnovelstrategiesbasedonantimicrobialpeptides AT falangaannarita biofilmsnovelstrategiesbasedonantimicrobialpeptides AT libralatogiovanni biofilmsnovelstrategiesbasedonantimicrobialpeptides AT guidamarco biofilmsnovelstrategiesbasedonantimicrobialpeptides AT carotenutorosa biofilmsnovelstrategiesbasedonantimicrobialpeptides |